Increased survival after endotoxemia and CLP, improved cytokine profile after CLP sepsis, inhibited LPS-induced HMGB1 secretion, reduced vascular permeability, reduced expression of cellular adhesion molecules, reduced sepsis-mediated liver injury, reduced LPS-mediated cytokine release and lung injury. This evidence concerns the gene HMGB1 and serum lipopolysaccharide activity.